JW Pharmaceutical Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was KRW 1,095.63 million compared to KRW 1,008.68 million a year ago. Net income was KRW 14,426.2 million compared to KRW 982.23 million a year ago. Basic earnings per share from continuing operations was KRW 531.3725 compared to KRW 34.3137 a year ago. Basic earnings per share was KRW 531.3725 compared to KRW 34.3137 a year ago.
For the six months, sales was KRW 1,851.13 million compared to KRW 2,396.73 million a year ago. Net income was KRW 29,952.36 million compared to KRW 10,566.26 million a year ago. Basic earnings per share from continuing operations was KRW 1,215.6863 compared to KRW 421.5686 a year ago. Basic earnings per share was KRW 1,215.6863 compared to KRW 421.5686 a year ago.